NCT04966273 (BIOMICS) is a NA clinical trial of Microcatheter in Ischemic Heart Disease, sponsored by Biosensors Europe SA.

Who is sponsoring NCT04966273?

NCT04966273 is sponsored by Biosensors Europe SA.

What drugs are being tested in NCT04966273?

Interventions in NCT04966273: Microcatheter.

What condition does NCT04966273 study?

NCT04966273 studies Ischemic Heart Disease.

Is NCT04966273 still recruiting?

NCT04966273 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT04966273: BIOMICS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO) - BIOMICS

Completed NA Last updated 18 January 2023

What this trial tests

NA trial testing Microcatheter in Ischemic Heart Disease in 101 participants. Completed in 3 January 2023.

Timeline

18 March 2022

Primary endpoint
3 January 2023

3 January 2023

Quick facts

Lead sponsor	Biosensors Europe SA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	101
Start date	18 March 2022
Primary completion	3 January 2023
Estimated completion	3 January 2023
Sites	9 locations across United Kingdom

Drugs / interventions tested

Microcatheter

Conditions studied

Ischemic Heart Disease — all drugs for Ischemic Heart Disease →

Sponsor

Biosensors Europe SA — full company profile →

Who can join

18 and older, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Biosensors, the Sponsor would like to determine if the Biosensors Microcatheter is safe and effective in treating patients with CTO by assessing a composite of in-hospital cardiac death or myocardial infarction and device success (defined as successfully facilitate placement of a guidewire beyond the occluded coronary segment), respectively.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Safety and Effectiveness of a Novel Microcatheter in Coronary Chronic Total Occlusions-The BIOMICS Study.
Sidik N, McEntegart M, Joshi F, Owens C, et al · · 2024 · PMID 39132006 · DOI 10.1016/j.jscai.2024.102017

Verify or expand the search:

Other trials of Microcatheter

Trials testing the same drug.

NCT06460831 — A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versu · NA · not yet recruiting
NCT06030271 — A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross · NA · completed

Other recruiting trials for Ischemic Heart Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
NCT06712862 — A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR · recruiting
NCT07009418 — Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien · NA · recruiting
NCT06891456 — Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia · NA · recruiting

Other Biosensors Europe SA trials

Trials by the same sponsor.

NCT05643430 — ULTRA LONG: BioFreedom Ultra · NA · active not recruiting
NCT05799963 — ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD · NA · active not recruiting
NCT05505929 — eUltra 10k - Biofreedom Ultra · recruiting
NCT04796038 — Rise Semi Compliant Balloon Study in Patient With CAD · NA · completed
NCT03745066 — BioFreedom French Registry · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04966273 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Biosensors Europe SA
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04966273.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing